Role of Vascular NADH/NAPDH oxidase in atherogenesis
Role of Vascular NADH/NAPDH oxidase in atherogenesis
批准号:
12470154
负责人:
YOKOYAMA Mitsuhiro
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
活性氧(ROS)诱导的氧化应激参与多种血管疾病的发病机制,包括动脉粥样硬化和冠状动脉疾病。NADH/NADPH氧化酶是活性氧(ROS)的重要来源。最近,我们发现p22^<phox>是这种氧化酶的重要组成部分,在人类冠状动脉中表达,并且随着动脉粥样硬化的进展其表达增强。本研究旨在探讨NADH/NADPH氧化酶在多种血管疾病发病机制中的功能重要性。我们检测了溶血磷脂酰胆碱(LPC),氧化LDL的致动脉粥样硬化成分,对培养内皮细胞中NADH/NADPH氧化酶活性的影响。培养的主动脉内皮细胞匀浆具有NADH/NADPH酶活性。LPC诱导o_2生成。因此内皮细胞中o_2的产生主要是由NADH/NADPH氧化酶系统介导的,LPC激活该氧化酶促进o_2的产生。研究了NADH/NADPH氧化酶在动脉粥样硬化性冠心病发病过程中的功能作用。为此,我们检测了定向冠状动脉粥样硬化切除术(DCA)标本中p22^<phox>的表达、氧化LDL的分布和ROS的产生。DCA标本取自稳定型(SAP)或不稳定型心绞痛(UAP)患者。ROS的产生与p22^<phox>和氧化LDL的分布密切相关。ROS与p22^<phox>或氧化LDL的表达有相关性。p22^<pfox b>基NADH/NADPH氧化酶产生的ROS可能介导LDL的氧化修饰,可能在动脉粥样硬化性冠状动脉疾病的发病机制中起重要作用。
英文摘要
Oxidative stress induced by reactive oxygen species (ROS) is implicated in the pathogenesis of a variety of vascular diseases including atherosclerosis and coronary artery disease. NADH/NADPH oxidase is an important source of reactive oxygen species (ROS).Recently, we demonstrated that p22^<phox>, an essential component of this oxidase, was expressed in human coronary arteries, and its expression was enhanced with the progression of atherosclerosis. The present study was undertaken to investigate the functional importance of NADH/NADPH oxidase in pathogenesis of various vascular diseases.We examined the effect of lysophosphatidylcholine (LPC), atherogenic component of oxidized LDL, on the activity of NADH/NADPH oxidase in cultured endthelial cells. Homogenates of cultured aortic endothelial cell had the enzymatic activity of NADH/NADPH. LPC induced O_2-generation. Thus the production of O_2-in endothelial cells is mainly mediated by the NADH/NADPH oxidase system and LPC activates this oxidase to enhance O_2-production.The functional role of NADH/NADPH oxidase in pathpgenesis of atherosclerotic corbriary disease was investigated. For this aim, the expression of p22^<phox>, distribution of oxidized LDL and generation of ROS in directional coronary atherectomy (DCA) specimens were examined. DCA specimens were obtained from patients with stable (SAP) or unstable angina pectoris (UAP). ROS generation was closely associated, with the distribution of p22^<phox> and oxidized LDL. There was a correlation between ROS and the expression of p22^<phox> or oxidized LDL. These factors of UAP were significantly higher compared with SAP. ROS generated by p22^<pfox> -based NADH/NADPH oxidase likely mediate oxidative modification of LDL, and it might play a major role in pathogenesis of atherosclerotic coronary artery disease.
期刊论文(118)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Rikitake Y: "Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine"Biochem Biophys Res Commun.. 281(5). 1291-1297 (2001)
Rikitake Y:“溶血磷脂酰胆碱诱导 COX-2 的信号机制”Biochem Biophys Res Commun. 281(5)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seno T, Inoue N, Gao D, Okuda M, Sumi Y, Matsui K, Yamada S, Hirata KI, Kawashima S, Tawa R, Imajoh-Ohmi S, Sakurai H, Yokoyama M.: "Involvement of NADH/NADPH oxidase in human platelet ROS production"Thromb Res.. 103(5). 399-409 (2001)
Seno T、Inoue N、Gao D、Okuda M、Sumi Y、Matsui K、Yamada S、Hirata KI、Kawashima S、Tawa R、Imajoh-Ohmi S、Sakurai H、Yokoyama M.:“NADH/NADPH 氧化酶参与
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Rikitake Y, Hirata K, Kawashima S, Takeuchi S, Shimokawa Y, Kojima Y, Inoue N, Yokoyama M.: "Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine"Biochem Biophys Res Commun. 281(5). 1291-7 (2001)
Rikitake Y、Hirata K、Kawashima S、Takeuchi S、Shimokawa Y、Kojima Y、Inoue N、Yokoyama M.:“溶血磷脂酰胆碱诱导 COX-2 的信号机制”Biochem Biophys Res Commun。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, Nishi H, Inoue N, Yokoyama M.: "Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits"Athero
Rikitake Y、Kawashima S、Takeshita S、Yamashita T、Azumi H、Yasuhara M、Nishi H、Inoue N、Yokoyama M.:“氟伐他汀(一种 HMG-CoA 还原酶抑制剂)的抗氧化特性有助于预防胆固醇动脉粥样硬化
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshiyuki Rikitake: "Inhibition of endothelium-dependent arterial relaxation by oxidized phosphatidylcholine."Atherosclerosis.. 152. 79-87 (2000)
Yoshiyuki Rikitake:“氧化磷脂酰胆碱抑制内皮依赖性动脉舒张。”动脉粥样硬化.. 152. 79-87 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 58 条
The role of endothelial lipase in pathogenesis of atherosclerosis : A novel therapeutic target for raising HDL cholesterol
-
批准号:16390226
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2004
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
Balance-shift in the production of NO and superoxide via endothelial nitric oxide synthase in atherogenesis
-
批准号:14370227
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:2002
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
Development of ELISA system for plasma EDL and its clinical application for atherosclerosis
-
批准号:13557066
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.71万
-
财政年份:2001
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
Analysis of the role of NO in cardiovascular disease by use of transgenic mice overexpressing endothelial NO synthase.
-
批准号:10470165
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$2.3万
-
财政年份:1998
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
The role of endothelial nitric oxide synthase in cardiovascular regulation. -approach using genetic engineering.
-
批准号:08457209
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1996
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
Serotonin receptors and ischemic heart disease
-
批准号:07557345
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$2.3万
-
财政年份:1995
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
An approach to understand the pathophysiological role of endothelial constitutive nitric oxide synthase
-
批准号:06454292
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.61万
-
财政年份:1994
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
An approach to understand the interaction of lipoproteins and vascular endothelial cells
-
批准号:04454266
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1992
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
An approach to understand the mechanism and pathogenesis of production and release of endothelium-derived relaxing factor by molecular and cellular biology technique.
-
批准号:02454257
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1990
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
An approach to understand the pathogenesis of coronary artery spasm by molecular and cellular biology techniques
-
批准号:63570396
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1988
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
Transmembrane signal transduction in vascular smooth muscle and endothelial cells and physilogic responese
-
批准号:61570416
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1986
-
负责人:YOKOYAMA Mitsuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
-
批准号:91957111
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2019
-
负责人:李佩盈
-
依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
-
批准号:81170251
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:刘梅林
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
-
批准号:81000086
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:江立生
-
依托单位:
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
-
批准号:30971216
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈文强
-
依托单位:
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
-
批准号:30871040
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:陈文强
-
依托单位: